Proposing a redefinition of pharmaceutical care

Area of Science:

• Clinical Pharmacy
• Patient Care Management
• Healthcare Quality Improvement

Background:

• Practicing pharmacists often manage thousands of patients, lacking clear guidance for patient identification and prioritization.
• Current pharmaceutical care models do not adequately direct pharmacists toward specific high-risk patient groups.
• This gap can lead to inconsistent allocation of pharmacist resources and suboptimal patient outcomes.

Purpose of the Study:

• To advocate for a revised definition and care processes within pharmaceutical care.
• To emphasize the need for pharmacists to be officially accountable for high-risk patient populations.
• To ensure consistent focus on patients most likely to experience drug- or disease-induced morbidity.

Main Methods:

• Conceptual analysis of existing pharmaceutical care definitions and processes.
• Literature review on patient prioritization strategies in clinical practice.
• Development of a framework for accountability to high-risk patient groups.

Main Results:

• Identified a critical need for structured patient prioritization in pharmaceutical care.
• Proposed modifications to the definition and processes of pharmaceutical care.
• Highlighted the importance of pharmacist accountability for specific, at-risk patient cohorts.

Conclusions:

• The current pharmaceutical care approach requires modification to effectively prioritize patients.
• Pharmacists must be formally accountable for managing high-risk patient groups to reduce morbidity.
• Implementing focused care strategies will enhance the impact of pharmaceutical services.